RESUMEN
INTRODUCTION: In this study, we assessed the outcomes of patients with dystonia who underwent surgery treatment following the same algorithm. PATIENTS AND METHODS: Eighty consecutive patients with dystonia were submitted to neurosurgical management by means of intrathecal pump implantation, pallidotomy or deep brain stimulation (GPi or VIM). These patients included 48 patients with primary dystonia and 32 patients with secondary dystonia. Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) was used to access pre- and post-operative outcomes. Patients were followed from 12 to 114 months. RESULTS: Mean improvement in BFMDRS score among patients with PrD was 87.54% and 42.21% for SeD. Hemidystonic patients in both groups (PrD, SeD) showed a mean improvement in BFMDRS of 71.05% with GPiDBS. Patients with SeD due to previous perinatal insults showed a mean improvement in BFMDRS of 41.9%, with better results in purely dyskinetic patients (mean improvement of 61.2%). CONCLUSION: Use of the proposed algorithm facilitated surgical decision planning, which translated in improved diagnostic rates, earlier interventions, appropriate management plans, and outcomes for both groups (PrD, SeD). Therefore, neuroimaging findings had a positive prognostic significance in the response to treatment in patients with primary dystonia compared with patients with secondary dystonia or distortion of basal ganglia anatomy. However, further studies in this line are warranted.
Asunto(s)
Distonía/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Estimulación Encefálica Profunda/métodos , Distonía/diagnóstico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Neuroquirúrgicos , Palidotomía , Calidad de Vida , Índice de Severidad de la Enfermedad , Tiempo , Resultado del Tratamiento , Adulto JovenRESUMEN
El síndrome de Melas es una enfermedad de herencia mitocondrial caracterizada por encefalopatía mitocondrial, acidosis láctica y eventos similares a ataque cerebrovascular, secundaria a una mutación en los genes que codifican las proteínas transportadoras de electrones, limitando la producción energética y generando disfunción multiorgánica, que afecta principalmente el sistema músculo esquelético y el sistema nervioso, lo que está en correlación con las características clínicas que presentan los pacientes. El diagnostico se basa en la sospecha clínica, los hallazgos paraclínicos e imagenológicos y la confirmación de la mutación a través del estudio genético. No existe tratamiento específico, se basa únicamente en el manejo sintomático y requiere apoyo multidisciplinario. Presentamos el caso de un paciente con antecedente de Melas, que ingresó por evento cerebrovascular isquémico bioccipital y correlación con hallazgos en neuroimágenes (espectroscopia y tractografía).
Melas syndrome is a disease characterized by mitochondrial inheritance of mitochondrial encephalopathy, lactic acidosis and events like stroke secondary to a mutation in the gene encoding the electron transport proteins limiting energy production and generating multiorgan dysfunction being affected mainly musculoskeletal system and the nervous system which correlates with the clinical characteristics presented by patients. The diagnosis is based on clinical suspicion, laboratory, and imaging findings and confirmation of the mutation through genetic study. No specific treatment is Is available, but symptomatic treatment is needed and requires multidisciplinary support. We report a patient with a history of Melas who who had bioccipital cerebral ischemic event and correlation with findings in neuroimaging (spectroscopy and tractography).